ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $223,000 | -93.8% | 11,345 | -94.6% | 0.00% | -100.0% |
| Q2 2018 | $3,609,000 | +17.2% | 208,410 | -3.8% | 0.01% | +20.0% |
| Q1 2018 | $3,080,000 | +18.3% | 216,539 | -1.9% | 0.01% | 0.0% |
| Q4 2017 | $2,604,000 | -19.9% | 220,645 | +60.5% | 0.01% | -28.6% |
| Q3 2017 | $3,252,000 | +175.4% | 137,511 | +129.4% | 0.01% | +133.3% |
| Q2 2017 | $1,181,000 | +524.9% | 59,943 | +494.8% | 0.00% | – |
| Q4 2016 | $189,000 | -42.2% | 10,077 | -35.7% | 0.00% | -100.0% |
| Q3 2016 | $327,000 | -28.0% | 15,670 | -11.9% | 0.00% | 0.0% |
| Q2 2016 | $454,000 | +27.9% | 17,782 | +32.6% | 0.00% | 0.0% |
| Q1 2016 | $355,000 | -42.2% | 13,408 | -6.6% | 0.00% | -50.0% |
| Q4 2015 | $614,000 | +82.2% | 14,356 | +13.0% | 0.00% | +100.0% |
| Q3 2015 | $337,000 | -13.1% | 12,709 | +9.0% | 0.00% | 0.0% |
| Q2 2015 | $388,000 | -0.5% | 11,655 | -0.6% | 0.00% | -50.0% |
| Q1 2015 | $390,000 | -24.4% | 11,729 | -7.1% | 0.00% | -33.3% |
| Q4 2014 | $516,000 | – | 12,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 7,106,955 | $139,652,000 | 2.69% |
| Malaga Cove Capital, LLC | 52,987 | $1,035,000 | 0.56% |
| PFM Health Sciences, LP | 1,699,100 | $33,387,000 | 0.49% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 75,000 | $1,474,000 | 0.43% |
| Spark Investment Management LLC | 320,400 | $6,295,000 | 0.36% |
| PFM Health Sciences, LP | 1,247,434 | $24,512,000 | 0.36% |
| Partner Investment Management, L.P. | 20,900 | $411,000 | 0.32% |
| Kazazian Asset Management, LLC | 14,454 | $284,000 | 0.27% |
| DLD Asset Management, LP | 271,500 | $5,327,000 | 0.26% |
| Partner Investment Management, L.P. | 15,516 | $305,000 | 0.23% |